Exicure, Inc. (NASDAQ:XCUR – Get Free Report) was the recipient of a significant increase in short interest in the month of ...
13 天
Zacks Small Cap Research on MSNDWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion ...DWTX READ THE FULL DWTX RESEARCH REPORT Business Update First Patient Dosed in Phase 2b Trial of Halneuron® On March 18, 2025 ...
Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...
We generated induced excitatory neurons (iNeurons, iNs) from chimpanzee, bonobo, and human stem cells by expressing the transcription factor neurogenin-2 (NGN2). Single-cell RNA sequencing showed that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果